You just read:

Statement from FDA Commissioner Scott Gottlieb, M.D., on FDA's steps on naming of biological medicines to balance competition and safety for patients receiving these products

News provided by

U.S. Food and Drug Administration

Mar 07, 2019, 09:31 ET